Valuation — not yet established
No valuation for GRO Biosciences is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($91.5M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for GRO Biosciences
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Early Stage VC | $27.4M | ▮ | ▮ |
| Mar 2019 | Seed Round | $3.7M | ▮ | ▮ |
| Aug 2017 | Seed Round | $2.1M | ▮ | ▮ |
How GRO Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For GRO Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has GRO Biosciences raised?
- GRO Biosciences has raised $91.5M in total funding across 3 recorded rounds.
- When did GRO Biosciences last raise?
- GRO Biosciences last raised in Jul 2024 (Early Stage VC), raising $27.4M.